RADICAVA®


 
 
 
 
 
 
 
 
 


 

RADICAVA® (Edaravone) is a prescription drug used for the treatment of Amyotrophic Lateral Sclerosis.

RADICAVA® is manufactured by Mitsubishi Tanabe.

Administration and Dosage:

Administration of RADICAVA® is initially 14 days of intravenous infusion followed by a 14-day drug-free period with subsequent treatment cycles being 10 days out of 14 of intravenous infusion, followed by 14 day drug free periods.

Common Side Effects:

The more common side effects of RADICAVA® include hypersensitivity (allergic) reactions and sulfite allergic reactions.

More Information:

Please read the full Prescribing Information and Patient Information for RADICAVA® and discuss any questions you have with your doctor.

Ready to Schedule an Appointment?

Please CLICK HERE to get started.

Indication:

RADICAVA® is indicated to treat:

  • Amyotrophic Lateral Sclerosis